Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China.
Revenue is primarily driven by Sales Of Health Care Supplement (34.1%) and Net Product Sales (26.2%).
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Revenue by Segment
No significant events in the past 90 days.